Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal | Rheumatology | Nephrology | Family Medicine
Disease Category: Gout (Hyperuricemia)
Location: United States, MI
Clinical Trial Details
Research Study Summary
Phase III Gout Study
This long term study evaluates the safety and efficacy of an investigational treatment compared to allopurinol in people who have both gout and cardiovascular disease. Participants will receive compensation for their time and travel; $50 for each completed office visit and $15 for each completed telephone call throughout the study. There are up to 7 scheduled visits in the first year and every 6 months thereafter. The study is expected to last approximately 5 years. Study medication, examinations and bloodwork will be provided at no cost.
Patient Inclusion Criteria:
- History of cardiovascular disease
Patient Exclusion Criteria:
- History of Hep B, Hep C, or HIV.
To Learn more
Both Male and Female
Date Last Changed:
July 23, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.